Preclinical testing is critical for determining the safety and efficacy of a product before it is tested on humans in clinical trials and subsequent regulatory filing. It also speeds up discovery research by assisting with product development, validation, improving product quality, and obtaining regulatory approvals within the time-frames specified. A preclinical contract research organization assists manufacturing firms in a variety of ways, including lowering R&D costs, sharing associated risks, improving preclinical data quality, and gaining access to specialized resources such as talent pools and technology. As a result, a Preclinical CRO is expected to provide the necessary experience, knowledge, and skill to bring a product from concept to market.
Prado is one of the leading, global, independent market leaders in toxicity testing and preclinical services, with the goal of providing the highest possible quality Preclinical services and contributing towards generations of safe and cost-effective healthcare product development for humanity. Prado is gaining a solid reputation for providing high-quality services at reasonable prices. The company's scientific data is of the greatest quality, and its reports have a high acceptance rate with regulatory bodies, making product registration and approval easier. Prado helps the pharmaceutical, bio-pharma, biotech,
agrochemicals, stem cell, medical device, and animal health industries achieve regulatory requirements by delivering cost-effective, high-quality preclinical services.
It is both Prado's vision and commitment to instill our principles in all we do in order to produce high-quality integrated preclinical services, create a good atmosphere, and achieve safe and cost-effective healthcare product development for humanity”, says Dr. Pralhad Wangikar, CEO & Director, Prado.
“Prado has technical, research and development expertise to provide excellent service. We aim to work closely with our clients to understand their preclinical needs and develop programs to meet their goals in a timely manner. Prado can be a strategic and scientific, yet responsive, flexible and trustworthy partner”, he adds.
Objective-Driven Service Deliverability
Prado is known in the market for its unique range of services which include Toxicology Studies, Pharmacokinetic Studies, Pathology Services, Biology Studies, and Genotoxicity and Biocompatibility, risk assessment including preparation of PDE, OEL and AI reports. The company’s service delivery is backed by its team of seasoned professionals and its state-of-the-art infrastructure integrated with latest equipment and technologies.
It is both Prado's vision and commitment to instill our principles in all we do in order to produce high-quality integrated preclinical services, create a good atmosphere, and achieve safe and cost-effective healthcare product development for humanity
“To deliver exceptional service, Prado has technical, research, and development competence. We seek to collaborate closely with our clients to understand their preclinical needs and build programmes to fulfill their objectives on schedule. Prado can be a strategic and scientific partner who is also responsive, flexible, and trustworthy. Prado helps you succeed while also advancing the safety evaluation”, concludes Dr. Pralhad.Going forward, PRADO would be constantly evolving its capabilities to drive the needed innovation in the industry, wherein, it would be keeping itself relevant and abreast of the changing market dynamics.
We use cookies to ensure you get the best experience on our website. Read more...
